Cargando…

Interrogating a clinical database to study treatment of hypotension in the critically ill

OBJECTIVE: In intensive care, it is imperative to resolve hypotensive episodes (HEs) in a timely manner to minimise end-organ damage. Clinical practice guidelines generally recommend initial treatment with fluid resuscitation followed by vasoactive agent administration if patients remain hypotensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joon, Kothari, Rishi, Ladapo, Joseph A, Scott, Daniel J, Celi, Leo A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371576/
https://www.ncbi.nlm.nih.gov/pubmed/22685222
http://dx.doi.org/10.1136/bmjopen-2012-000916
_version_ 1782235227916075008
author Lee, Joon
Kothari, Rishi
Ladapo, Joseph A
Scott, Daniel J
Celi, Leo A
author_facet Lee, Joon
Kothari, Rishi
Ladapo, Joseph A
Scott, Daniel J
Celi, Leo A
author_sort Lee, Joon
collection PubMed
description OBJECTIVE: In intensive care, it is imperative to resolve hypotensive episodes (HEs) in a timely manner to minimise end-organ damage. Clinical practice guidelines generally recommend initial treatment with fluid resuscitation followed by vasoactive agent administration if patients remain hypotensive. However, the impact of such interventions on patient outcomes has not been clearly established. Hence, the objective of this study was to investigate the relationship between fluid and vasoactive agent interventions and patient outcomes, while highlighting the utility of electronic medical records in clinical research. DESIGN: Retrospective cohort study. SETTING: Intensive care units (ICUs) at a large, academic, tertiary medical center. PARTICIPANTS: Patients in Multi-parameter Intelligent Monitoring in Intensive Care II (a large electronic ICU database) who experienced a single HE during their ICU stay. 2332 patients had complete data. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome of interest was inhospital mortality. Secondary outcomes were ICU length of stay (LOS), HE duration, Hypotension Severity Index (defined as the mean arterial pressure curve area below 60 mm Hg during the HE) and rise in serum creatinine. RESULTS: Fluid resuscitation was associated with significantly shorter ICU LOS among ICU survivors (p=0.007). Vasoactive agent administration significantly decreased HE duration (p<0.001) and Hypotension Severity Index (p=0.002) but was associated with increased inhospital mortality risk (p<0.001), prolonged ICU LOS among ICU survivors (p=0.04) and rise in serum creatinine (p=0.002) after adjustment for confounders. Propensity score analyses as well as sensitivity analyses in treatment-, diagnosis- and ICU service-specific subpopulations corroborated the relationship between vasoactive agents and increased inhospital mortality. CONCLUSIONS: An adverse relationship between vasoactive agents and inhospital mortality was found in patients with hypotension. This study has implications for the care of critically ill patients with hypotension and illustrates the utility of electronic medical records in research when randomised controlled trials are difficult to conduct.
format Online
Article
Text
id pubmed-3371576
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-33715762012-06-14 Interrogating a clinical database to study treatment of hypotension in the critically ill Lee, Joon Kothari, Rishi Ladapo, Joseph A Scott, Daniel J Celi, Leo A BMJ Open Intensive Care OBJECTIVE: In intensive care, it is imperative to resolve hypotensive episodes (HEs) in a timely manner to minimise end-organ damage. Clinical practice guidelines generally recommend initial treatment with fluid resuscitation followed by vasoactive agent administration if patients remain hypotensive. However, the impact of such interventions on patient outcomes has not been clearly established. Hence, the objective of this study was to investigate the relationship between fluid and vasoactive agent interventions and patient outcomes, while highlighting the utility of electronic medical records in clinical research. DESIGN: Retrospective cohort study. SETTING: Intensive care units (ICUs) at a large, academic, tertiary medical center. PARTICIPANTS: Patients in Multi-parameter Intelligent Monitoring in Intensive Care II (a large electronic ICU database) who experienced a single HE during their ICU stay. 2332 patients had complete data. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome of interest was inhospital mortality. Secondary outcomes were ICU length of stay (LOS), HE duration, Hypotension Severity Index (defined as the mean arterial pressure curve area below 60 mm Hg during the HE) and rise in serum creatinine. RESULTS: Fluid resuscitation was associated with significantly shorter ICU LOS among ICU survivors (p=0.007). Vasoactive agent administration significantly decreased HE duration (p<0.001) and Hypotension Severity Index (p=0.002) but was associated with increased inhospital mortality risk (p<0.001), prolonged ICU LOS among ICU survivors (p=0.04) and rise in serum creatinine (p=0.002) after adjustment for confounders. Propensity score analyses as well as sensitivity analyses in treatment-, diagnosis- and ICU service-specific subpopulations corroborated the relationship between vasoactive agents and increased inhospital mortality. CONCLUSIONS: An adverse relationship between vasoactive agents and inhospital mortality was found in patients with hypotension. This study has implications for the care of critically ill patients with hypotension and illustrates the utility of electronic medical records in research when randomised controlled trials are difficult to conduct. BMJ Group 2012-06-08 /pmc/articles/PMC3371576/ /pubmed/22685222 http://dx.doi.org/10.1136/bmjopen-2012-000916 Text en © 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Intensive Care
Lee, Joon
Kothari, Rishi
Ladapo, Joseph A
Scott, Daniel J
Celi, Leo A
Interrogating a clinical database to study treatment of hypotension in the critically ill
title Interrogating a clinical database to study treatment of hypotension in the critically ill
title_full Interrogating a clinical database to study treatment of hypotension in the critically ill
title_fullStr Interrogating a clinical database to study treatment of hypotension in the critically ill
title_full_unstemmed Interrogating a clinical database to study treatment of hypotension in the critically ill
title_short Interrogating a clinical database to study treatment of hypotension in the critically ill
title_sort interrogating a clinical database to study treatment of hypotension in the critically ill
topic Intensive Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371576/
https://www.ncbi.nlm.nih.gov/pubmed/22685222
http://dx.doi.org/10.1136/bmjopen-2012-000916
work_keys_str_mv AT leejoon interrogatingaclinicaldatabasetostudytreatmentofhypotensioninthecriticallyill
AT kotharirishi interrogatingaclinicaldatabasetostudytreatmentofhypotensioninthecriticallyill
AT ladapojosepha interrogatingaclinicaldatabasetostudytreatmentofhypotensioninthecriticallyill
AT scottdanielj interrogatingaclinicaldatabasetostudytreatmentofhypotensioninthecriticallyill
AT celileoa interrogatingaclinicaldatabasetostudytreatmentofhypotensioninthecriticallyill